Background
Breast cancer-related lymphoedema (BCRL) is reported in up to 61% of patients following axillary treatment.1 Lymphatic surgical techniques spanning preventive, reconstructive, and therapeutic strategies have emerged across the treatment pathway. This review summarises evidence at each stage of management.
Methods
A narrative review was performed, drawing on systematic reviews, meta-analyses and cohort studies to evaluate axillary reverse mapping (ARM), lymphovenous anastomosis (LVA), and vascularised lymph node transfer (VLNT) in preventive, reconstructive, and therapeutic settings.
Results
ARM, a lymphatic preservation technique, reduces the incidence of lymphoedema to 4.8%.2 Prophylactic LVA (LYMPHA) has been shown in long-term cohort data to reduce incidence to 1.5-2.5%.3 VLNT combined with autologous free-flap reconstruction achieves circumference reductions of 30-45%.4 For established BCRL, LVA and VLNT both demonstrate significant improvement over conservative therapy, with selection guided by lymphatic function and disease stage.5
Conclusion
Collectively, these findings support a stage-based approach, with preventive strategies reducing BCRL incidence and microsurgical techniques improving established disease.